It is with heavy hearts that we share the passing of an incredible member of our community, Ivy Elkins. The impact that Ivy has had on the lung cancer community cannot be adequately expressed in words. She touched so many people’s lives, both directly and indirectly, through her tireless advocacy for patients.

Whether through her official capacity as co-founder of the EGFR Resisters, or through her representation of lung cancer patients with the Department of Defense CDRMP, the NIH, and countless advocacy groups, Ivy was able to connect with others in a way that brought hope to the fore. She was instrumental in spearheading numerous fundraisers for lung cancer research. Ivy was also one of the people we counted on to host discussions that helped tie lung cancer research to its impact on people. She helped to forge connections between researchers and the beneficiaries of the research, always focused on the human element of advancements being made.

Her influence on lung cancer research and the lung cancer community will be felt for years to come. She will be sorely missed by us all.